Aerodynamic Measurements in the Pediatric Population
Launched by UNIVERSITY OF WISCONSIN, MADISON · May 8, 2025
Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Aerodynamic Measurements in the Pediatric Population," aims to understand how to best assess the voices of children aged 4 to 17 who do not have any diagnosed voice problems. Researchers want to create a database that compares normal voices with those that have issues, helping to identify what makes a healthy voice different from one that is not functioning well.
To participate, children should be between 4 and 17 years old and have a normal voice without any history of voice or health issues. Those with certain conditions, like neuromuscular disorders or laryngeal problems, are not eligible. Participants will take part in a single 60-minute session where they will undergo tests involving different methods of measuring how air flows when they speak. This study is particularly important as it will help us learn more about children's vocal health and improve future assessments.
Gender
ALL
Eligibility criteria
- Inclusion Criteria - Healthy Control:
- • Age 4-17 years
- • Normal voice
- • No history of voice or other pertinent health disorders
- Exclusion Criteria - Healthy Control:
- • Neuromuscular disorder affecting the larynx
- • History of respiratory or laryngeal disease
- • History of smoking
- • Hearing impairment
- • Cognitive impairment that might impact ability to perform the tasks required by the study
- Inclusion Criteria - Abnormal Voice:
- • Age 4-17
- • Laryngeal pathology
- Exclusion Criteria - Abnormal Voice:
- • No laryngeal disorder
About University Of Wisconsin, Madison
The University of Wisconsin-Madison is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources, including cutting-edge facilities and a diverse pool of expert researchers, to conduct rigorous studies that address critical health challenges. The institution's focus on translating research findings into practical applications fosters the development of new treatments and interventions, ultimately contributing to improved patient outcomes and public health initiatives. As a sponsor of clinical trials, the University of Wisconsin-Madison is dedicated to upholding the highest ethical standards and ensuring participant safety throughout the research process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Iowa City, Iowa, United States
Madison, Wisconsin, United States
Patients applied
Trial Officials
Jack Jiang, MD
Principal Investigator
University of Wisconsin, Madison
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported